Lipids in Pulmonary Drug Delivery

個数:

Lipids in Pulmonary Drug Delivery

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 544 p.
  • 言語 ENG
  • 商品コード 9780443223747
  • DDC分類 615.19

Full Description

Lipid in Pulmonary Drug Delivery explores the most recent advancements, strategies, and state-of-the-art technological progress in the development of lipid-based nanocarriers for pulmonary administration. The book presents wide coverage of various lipid-based nano-drug carriers such as liposomes, solid lipid nanoparticles, and nanoemulsions intended for the administration of drugs through the pulmonary route to treat different conditions. It also includes a general description of the formulation aspects of various lipid-based drug delivery vehicles, post-production processing, and biofate aspects with special emphasis on the pulmonary microenvironment.

In addition, the authors include an update on the clinical status of the potential lipid nanocarriers used for effective management of the pulmonary related diseases. Written in a technical way covering the latest advancements in lipid-based drug delivery for pulmonary administration, this book is a useful reference for researchers, scientists, and graduate and postgraduate students working on, or planning, research in the field of lipid-based nano-drug pulmonary delivery platforms.

Contents

Lipid Nanotechnology
Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
Aerodynamics and Deposition of Lipid-Based Nanocarriers in Lungs
Liposome as a Versatile Carrier for Pulmonary Drug Delivery
Advancements in Nano-Structured Lipid Carrier (NLCs) as Drug Delivery Vehicle in Lungs
Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
Lipid-Based Drug Delivery for Lung Cancer
Exploring the State-of-Art of Lipid Nanomedicines for Obstructive Pulmonary Diseases
Lipid-Based Drug Delivery for Pulmonary Microbial Infections
Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
Biofate of Lipid-Based Nanomedicine After Pulmonary Administration
Surface Modification of Lipid-Based Drug Delivery for Lungs
Evaluation of Lipid-Based Formulation for Pulmonary Delivery
Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
Translation of Lipid-Based Formulation for Pulmonary Drug Delivery System: Clinical Status
Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications
Lipid-Based Vaccines Against Viruses Including COVID-19
Lipid-Based Nanocarriers in the Management of Cystic Fibrosis: A Pulmonary Complication
Pulmonary Drug Delivery of Lipid-Based Formulations via Nebulizers
Lipid-Based Peptide and Gene Delivery to Lungs

最近チェックした商品